The majority of adult patients with rheumatoid arthritis (RA) have rheumatoid factor (RF) , that is, a 19S IgM globulin directed against the Fc piece of IgG. RFs are capable of agglutinating latex particles (LFI) and sheep erythrocytes (SCAT) coated with IgG. About 20% of patients with RA do not contain RF by the standard tests, that is, their serum does not contain agglutinating IgM-RF. However, 'hidden' IgM-RFs have been demonstrated in the serum of adults with seronegative RA, but their significance is yet to be defined (Allen and Kunkel, 1966; Bluestone et al., 1969; Cracchiolo et al., 1970) . In addition, IgG-RFs existing as 'intermediate complexes' have been demonstrated in the sera of adult RA patients (Pope et al., 1974 (Pope et al., , 1975 . Although both 1gM and IgG-RFs are thought to be intimately involved in the inflammatory process leading to tissue damage in RA, their precise role is still unclear.
Complement fixation by IgM-RF has been shown to occur predominantly through classical pathway, thus enabling it to participate in the inflammatory reaction (Tanimoto et al., 1975; Nydegger et al., 1977 Kaplan et al., 1978 . We have recently shown that qualitative differences in IgM-RF complement fixation exist in seropositive RA patients which may act independently from the concentration of IgM-RF in the serum (unpublished results). More recently, the presence of hidden complement fixing IgM-RF has been demonstrated in the IgM fractions of the majority of patients with juvenile RA (especially the polyarticular type) when these same IgM-RF remained undetectable by the standard agglutination tests in the serum. Furthermore, the haemolytic titre correlated with disease activity (Moore et al., 1978) . This study was undertaken to determine the possible significance and presence or absence of hidden complement fixing IgM-RFs in adults with seronegative RA.
Materials and methods
SOURCE OF SERA Sera were obtained from 27 patients with definite or classical RA (American Rheumatism Association criteria) all of whom were agglutinin negative by the standard LFT or SCAT. (Several sera were kindly provided by Drs Robert Shapiro and Kenneth Weisner). Additionally, sera were obtained from 13 RA patients (ARA criteria) who were agglutinin positive; 10 JRA patients with agglutinin-negative sera; 7 patients who had oligoarticular asymmetrical peripheral arthritis and were agglutinin negative but positive for the HLA B27; and 6 normal volunteers. All sera were heat inactivated at 560C for 30 minutes and incubated with 1:5 dilution washed packed sheep erythrocytes (SRBC) at 370C for 90 minutes to remove natural antibody to SRBC.
MEASUREMENT OF COMPLEMENT-INDUCED HAEMOLYSIS
The IgG fraction of rabbit anti-SRBC haemolysin Lack of hidden complement fixing IgM rheumatoid factor in adult seronegative rheumatoid arthritis 65 (Cappel Laboratories, Downington, PA) was reduced and alkylated so as to abolish its ability to fix complement (Tanimoto et al., 1975) . The haemolysin was further treated with 0 15 M glycine-HC1 at pH 2-5 for 90 minutes at 220C and dialysed back to neutrality with phosphate buffered saline (PBS) pH 7 * 32. The latter allowed for hybridisation of the IgG haemolysin, which in turn allows for a higher sensitisation of the SRBC without attendant agglutination (Nisonoff and Palmer, 1964) .
Complement-induced haemolysis by IgM-RF was quantified in tube assays. The patient's serum was diluted serially in 0 15 M barbitone buffered saline containing 0 1-% gelatin and optimal concentrations of Ca+ + and Mg+ + (GVB+ +). To each dilution a standard amount of 1 % sensitised SRBC was added. After incubation at 370C for 60 minutes and 40C for 90 minutes the cells were washed once, and 1:40 diluted SRBC-absorbed guinea-pig serum (Pel-Freez, Rogers, Arkansas) was added as a source of complement. After another 60 minutes at 370C haemoglobin released into the supernatant was assayed at 412 nm.
PREPARATION OF IGM AND IGM-RF
Companion sera after heat inactivation and absorption with SRBC obtained from all the patients as mentioned above were then applied to a Sephadex G-200 (Pharmacia Fine Chemicals Inc., Piscataway, NJ) gel filtration column, equilibrated with 0 1 N pH 4 0 acetate buffer. The first peak eluted in the void volume contained IgM. It was dialysed against 0 15 M NaCl buffered to pH 7 32 with sodium phosphate (PBS) and concentrated by pervaporation to a volume equal to or less than the serum specimen originally applied to the column. These preparations were examined by double immunodiffusion in agar at a concentration of 10 mg/ml by means of antisera specific for IgM, IgG, and IgA. Only IgM was detected. The IgM fractions were then used in the complement dependent haemolytic assay exactly as described for the sera.
Results
The results of IgM-RF complement fixation present in both the whole sera and isolated IgM fractions at 1:2 dilution are displayed in Fig. 1 . The optical density is a measurement of haemoglobin release mediated by complement and is therefore directly proportional to the degree of complement fixation mediated by IgM-RF. We could not detect any complement fixing IgM-RF in the 27 seronegative adult RA patients studied either in the whole serum or in the isolated IgM fraction. Although there are occasional seronegative sera and isolated IgMs that showed low-grade haemolysis at dilutions of 1:2, they were all completely negative when diluted to 1:16 or greater, which is not statistically different from the normal and negative control groups. This is in contrast to the seropositive adult RA group, whose IgM-RF showed good complement fixation in both the whole serum and isolated IgM, and with the polyarticular juvenile RA group, whose serum showed no haemolytic capability but whose isolated IgM had good haemolytic capability. Thus, our results show the absence in the serum of 'hidden' complement fixing IgM-RF in the 27 adult seronegative RA patients studied here. There was no evidence for complement fixing IgM-RF in the serum or separated IgM fraction in either of the negative control groups, the HLA B27 + group, or the normal adults. Fig. 2 reaction leading to tissue damage in this disease (Weissman, 1972) . Patients with high titres of circulating IgM-RF have more aggressive joint disease and a higher incidence of extra articular manifestations (Mongan et al., 1969) . Furthermore, the rheumatoid synovium has been shown to produce
TgM-RF and IgG and to contain immune complexes consisting of 1gM, IgG, and C3 (Schurr et al., 1975; Taylor-Upsahl et al., 1977) . Also, synovial fluid complement is decreased in RA, which has been correlated with more severe joint damage, and complexes of IgM, IgG, and C3 have been found in phagocytic cells within the joint fluid (Schur et al., 1975; Zubler et al., 1976; Carson et al., 1977) . IgM-RF has been shown to fix complement predominantly by the classical pathway, which enables it to participate in the inflammatory reaction (Tanimoto et al., 1975; Nydegger et al., 1977; Kaplan et al., 1978) . Recently 'hidden' complement fixing IgM-RF has been demonstrated in patients with juvenile RA, especially the polyarticular group. This was present in the isolated IgM fraction separated under acid conditions. Moreover, the degree of IgM-RF complement fixation in these patients correlated with disease activity, a correlation which was not present by the standard SCAT or LFT. Thus it was postulated that the haemolytic assay might be detecting a group of IgM-RF molecules different from those producing agglutination and that these complement fixing IgM-RF molecules could have significant pathogenic effects by means of their ability to participate in the inflammatory reaction. The whole sera of these patients did not show agglutinating or complement fixing haemolytic capability (Moore et al., 1978) .
'Hidden' IgM-RF possessing agglutinin activity has been detected in the serum of adults with seronegative RA, suggesting apathogenicroleforIgM-RF in that patient population (Allen and Kunkel, 1966) . Furthermore, IgM-RF separated under acid conditions showed a greater avidity for monomeric IgG than that separated under neutral conditions. This difference in avidity has been shown to be due to the multivalency of the acid-separated IgM-RF molecules (Dissanayake et al., 1977 
